Treatment with Adalimumab ( DrugBank: Adalimumab )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
96	クローン病	2

96. クローン病

---

臨床試験数 : 2,400 /  薬物数 : 1,391 - (DrugBank : 267) / 標的遺伝子数 : 170 - 標的パスウェイ数 : 215

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2017-004588-11-NL (EUCTR)	10/09/2019	10/09/2019	Control Crohn Safe Trial: Long term outcome and tolerability of six months adalimumab as initial treatment for newly diagnosed Crohn's disease versus standard step-up treatment.	Control Crohn Safe Trial: Long term efficacy and safety of periodic treatment with adalimumab versus standard step-care for newly diagnosed Crohn's disease. - CoCroS trial	The chronic inflammatory bowel disease Crohn's disease;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]	Trade Name: Humira	University Maastricht	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	158	Phase 4	Netherlands
2	NCT01144156 (ClinicalTrials.gov)	July 2007	13/6/2010	Small Bowel Mucosal Healing Induced by Adalimumab in Crohn's Disease Patients as Assessed by Capsule Endoscopy	Small Bowel Mucosal Healing Induced by Adalimumab in Crohn's Disease Patients as Assessed by Capsule Endoscopy	Crohn's Disease	Drug: Treatment with Adalimumab	Rabin Medical Center	Abbott	Not yet recruiting	18 Years	N/A	Both	30	N/A	Israel